A new study released by the Schroeder Institute for Tobacco Research and Policy Studies claims that there is no scientific evidence that nicotine by itself does causes cancer. As a result, the researchers conclude that vaping nicotine-enhanced e-liquids has a substantially less negative health impact than smoked tobacco products. It’s the tar and the thousands of other toxic chemicals that e-cigs lack that can really kill.
The study goes on to claim that the nicotine from vaping products is also far less addictive than the conventional smoking. While e-cig use can be a contributing factor to the health risks associated with heart disease and respiratory disorders, the associated risks are but a fraction compared to traditional cigarettes. The notion that vaping technology and e-cigs are just as deadly as conventional cigarettes is simply not true.
“By allowing smokers to transition to products that deliver nicotine without smoke’s toxicity, MRTPs (Modified Risk Tobacco Products) could reduce the population’s exposure to the toxic combustion products inherent in smoking. The concept that ‘people smoke for nicotine but they die from the tar’ has been widely accepted for decades (Russell, 1976), and was recently reinforced by the 2014 Surgeon General’s Report, which noted the potential for noncombustible nicotine-delivery products to reduce morbidity and mortality (U.S. Department of Health and Human Services, 2014).”
Schroeder Institute discusses Mitch Zeller and the FDA
The study goes on to suggest that certain U.S. government agencies are either purposely or unintentionally misleading the American Public by likening nicotine with tobacco. Since little of the physical harm from smoking is a direct or indirect result of the included nicotine, public officials like Mitch Zeller need to do a better job in educating the public about the differences between vaping and smoking.
“Mitch Zeller, the current director of the FDA’s Center for Tobacco Products, recognizing that ‘certain products pose more individual risk than others,’ has noted that the FDA’s truthinitiative.org p 6 regulatory authority has provided an ‘opportunity to create a comprehensive agency-wide nicotine regulatory policy.’ (U.S. Food and Drug Administration, 2013a). Reduction of nicotine levels in combustible tobacco products and introduction of MRTPs may have complementary effects on population harms.”
The Schroeder Institute is calling on government officials like Mitch Zeller of the FDA and others to “re-think nicotine use in order to sharpen and inform approaches to tobacco control policy and public health practice.” The authors believe that a fundamental reexamination of nicotine and its possible negative biological health risks needs to occur immediately, specifically in regards to e-cigs’ degree of addiction and the “behavioral or social consequences to individuals and society.”
The complete study by the Schroeder Institute can be located on online.